449 related articles for article (PubMed ID: 21215445)
1. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.
Martineau AR; Timms PM; Bothamley GH; Hanifa Y; Islam K; Claxton AP; Packe GE; Moore-Gillon JC; Darmalingam M; Davidson RN; Milburn HJ; Baker LV; Barker RD; Woodward NJ; Venton TR; Barnes KE; Mullett CJ; Coussens AK; Rutterford CM; Mein CA; Davies GR; Wilkinson RJ; Nikolayevskyy V; Drobniewski FA; Eldridge SM; Griffiths CJ
Lancet; 2011 Jan; 377(9761):242-50. PubMed ID: 21215445
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Vitamin D
Ganmaa D; Munkhzul B; Fawzi W; Spiegelman D; Willett WC; Bayasgalan P; Baasansuren E; Buyankhishig B; Oyun-Erdene S; Jolliffe DA; Xenakis T; Bromage S; Bloom BR; Martineau AR
Am J Respir Crit Care Med; 2017 Sep; 196(5):628-637. PubMed ID: 28692301
[TBL] [Abstract][Full Text] [Related]
3. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
Tukvadze N; Sanikidze E; Kipiani M; Hebbar G; Easley KA; Shenvi N; Kempker RR; Frediani JK; Mirtskhulava V; Alvarez JA; Lomtadze N; Vashakidze L; Hao L; Del Rio C; Tangpricha V; Blumberg HM; Ziegler TR
Am J Clin Nutr; 2015 Nov; 102(5):1059-69. PubMed ID: 26399865
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.
Daley P; Jagannathan V; John KR; Sarojini J; Latha A; Vieth R; Suzana S; Jeyaseelan L; Christopher DJ; Smieja M; Mathai D
Lancet Infect Dis; 2015 May; 15(5):528-34. PubMed ID: 25863562
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials.
Zhang J; Chen C; Yang J
Chin Med J (Engl); 2019 Dec; 132(24):2950-2959. PubMed ID: 31833904
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data.
Jolliffe DA; Ganmaa D; Wejse C; Raqib R; Haq MA; Salahuddin N; Daley PK; Ralph AP; Ziegler TR; Martineau AR
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30728208
[TBL] [Abstract][Full Text] [Related]
7. Genotype-independent association between profound vitamin D deficiency and delayed sputum smear conversion in pulmonary tuberculosis.
Junaid K; Rehman A; Saeed T; Jolliffe DA; Wood K; Martineau AR
BMC Infect Dis; 2015 Jul; 15():275. PubMed ID: 26193879
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
von Groote-Bidlingmaier F; Patientia R; Sanchez E; Balanag V; Ticona E; Segura P; Cadena E; Yu C; Cirule A; Lizarbe V; Davidaviciene E; Domente L; Variava E; Caoili J; Danilovits M; Bielskiene V; Staples S; Hittel N; Petersen C; Wells C; Hafkin J; Geiter LJ; Gupta R
Lancet Respir Med; 2019 Mar; 7(3):249-259. PubMed ID: 30630778
[TBL] [Abstract][Full Text] [Related]
9. Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
Sinha S; Thukral H; Shareef I; Desai D; Singh BK; Das BK; Dhooria S; Sarin R; Singla R; Meena SK; Pandey RM; Pandey S; Sethi S; Kajal A; Yadav R; Aggarwal AN; Bhadada S; Behera D
PLoS One; 2023; 18(3):e0272682. PubMed ID: 36996065
[TBL] [Abstract][Full Text] [Related]
10. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R
Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.
Wallis RS; Ginindza S; Beattie T; Arjun N; Likoti M; Edward VA; Rassool M; Ahmed K; Fielding K; Ahidjo BA; Vangu MDT; Churchyard G
Lancet Respir Med; 2021 Aug; 9(8):897-908. PubMed ID: 33740465
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
Martineau AR; James WY; Hooper RL; Barnes NC; Jolliffe DA; Greiller CL; Islam K; McLaughlin D; Bhowmik A; Timms PM; Rajakulasingam RK; Rowe M; Venton TR; Choudhury AB; Simcock DE; Wilks M; Degun A; Sadique Z; Monteiro WR; Corrigan CJ; Hawrylowicz CM; Griffiths CJ
Lancet Respir Med; 2015 Feb; 3(2):120-130. PubMed ID: 25476069
[TBL] [Abstract][Full Text] [Related]
13. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis.
Roth DE; Soto G; Arenas F; Bautista CT; Ortiz J; Rodriguez R; Cabrera L; Gilman RH
J Infect Dis; 2004 Sep; 190(5):920-7. PubMed ID: 15295697
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive vitamin A and D during pulmonary tuberculosis treatment: a randomized controlled trial with a 2 × 2 factorial design.
Wang J; Xiong K; Wang Q; Zhao S; Liu Y; Ma A
Food Funct; 2020 May; 11(5):4672-4681. PubMed ID: 32406431
[TBL] [Abstract][Full Text] [Related]
15. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.
Ralph AP; Waramori G; Pontororing GJ; Kenangalem E; Wiguna A; Tjitra E; Sandjaja ; Lolong DB; Yeo TW; Chatfield MD; Soemanto RK; Bastian I; Lumb R; Maguire GP; Eisman J; Price RN; Morris PS; Kelly PM; Anstey NM
PLoS One; 2013; 8(8):e70032. PubMed ID: 23967066
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Muhihi A; Aboud S; Nagu TJ; Ulenga N; Hong B; Wang M; Fawzi WW
Lancet HIV; 2020 Jul; 7(7):e463-e471. PubMed ID: 32621874
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Conde MB; Efron A; Loredo C; De Souza GR; Graça NP; Cezar MC; Ram M; Chaudhary MA; Bishai WR; Kritski AL; Chaisson RE
Lancet; 2009 Apr; 373(9670):1183-9. PubMed ID: 19345831
[TBL] [Abstract][Full Text] [Related]
18. Daily adjunctive therapy with vitamin D
Bekele A; Gebreselassie N; Ashenafi S; Kassa E; Aseffa G; Amogne W; Getachew M; Aseffa A; Worku A; Raqib R; Agerberth B; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
J Intern Med; 2018 Sep; 284(3):292-306. PubMed ID: 29696707
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial.
Mohseni H; Amani R; Hosseini SA; Ekrami A; Ahmadzadeh A; Latifi SM
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2065-2072. PubMed ID: 31350967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
